Cornerstone Robotics Secures EU and Singapore Approval for SentireĀ®
Hong Kong, China, May 25, 2026 Cornerstone Robotics (CSR) has announced that its SentireĀ® Endoscopic Surgical System has officially...
ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
Hong Kong, China, May 25, 2026 Cornerstone Robotics (CSR) has announced that its SentireĀ® Endoscopic Surgical System has officially...
Hong Kong, China ā May 25, 2026 Cornerstone Robotics (CSR) announced that its SentireĀ® Endoscopic Surgical System has officially...
BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...
SANTA CLARA, Calif., United States ā May 5, 2026 Johnson & Johnson has announced pivotal clinical study results for...
BOCA RATON, Fla., April 1, 2026 Allevion Medical⢠announced that the U.S. Food and Drug Administration (FDA) has granted...
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
SAN JOSE, Calif., March 12, 2026 PROCEPT BioRobotics has announced the international launch of its HYDROSĀ® Robotic System, a...
AMSTERDAM, the Netherlands, March 3, 2026 The SHERPA research consortium, coordinated by Royal Philips, has initiated seven clinical studies...
February 24, 2026 ā Mumbai, India & Naples, Florida, USA Global pharmaceutical leader Lupin Limited has announced that it...
February 24, 2026 ā Redwood City, California, USA The U.S. Food and Drug Administration (FDA) has granted regulatory clearance...
